Publications by authors named "A M Kats"
Article Synopsis
- Patients on long-term opioid therapy for chronic pain often still suffer from unrelieved pain and quality of life issues.
- This study compared two approaches for managing these patients: an integrated pain team (IPT) focused on holistic care versus pharmacist collaborative management (PCM) concentrated on medication optimization.
- Results showed similar outcomes for both groups in terms of pain response and opioid dosage reduction after 12 months, indicating that both methods can be effective in managing chronic pain.
Article Synopsis
- The study investigates the association between frailty, measured using the Study of Osteoporotic Fractures (SOF) phenotype, and increased healthcare costs among older adults with Medicare.
- It analyzes data from over 8,000 community-dwelling seniors, comparing costs related to frailty as defined by the SOF and the more complex Cardiovascular Health Study (CHS) phenotype.
- Results show that SOF phenotypic frailty is linked to significant incremental healthcare costs, comparable to those identified by the CHS phenotype, indicating the importance of recognizing frailty in clinical settings for cost management.
Objective: Virtually anything can be ranked; the (USNWR or US News) ranks the top 50 hospitals specializing in cardiology, heart, and vascular surgery. Here the authors propose validating the effectiveness of rankings by comparing differences among the USNWR metrics across the top 50 hospitals.
Methods: The ranking system for the top 50 hospitals specializing in cardiology, heart, and vascular surgery was derived from 16 variant scores.
Functional Impairments, Phenotypic Frailty, and Sector-Specific Incremental Healthcare Costs in Older Adults.
J Gerontol A Biol Sci Med Sci
November 2024
Background: This study quantifies incremental healthcare expenditures of functional impairments and phenotypic frailty in specific healthcare sectors.
Methods: Pooled 2023 analysis of 4 prospective cohort studies linked with Medicare claims including 4 318 women and 3 847 men attending an index examination (2002-2011). Annualized inpatient, skilled nursing facility (SNF), home healthcare (HHC), and outpatient costs (2023 dollars) ascertained for 36 months following index examination.
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report.
Pediatr Rheumatol Online J
September 2024
Article Synopsis
- Juvenile Dermatomyositis (JDM) is a rare autoimmune disorder with various subtypes, and anti-MDA5 is one of the associated myositis-specific antibodies, though treatment protocols are not well defined.
- A case study details a previously healthy 14-month-old girl with anti-MDA5 JDM presenting symptoms like rash, weakness, and liver issues, ultimately responding well to treatment with steroids and tofacitinib.
- This case highlights the importance of considering anti-MDA5 JDM when diagnosing patients with liver, muscle, and skin symptoms, emphasizing the need for standardized treatment approaches and more research into the mechanisms of the disease.